A model‐based analysis of the hip project for breast cancer screening
- 15 August 1990
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 46 (2), 207-213
- https://doi.org/10.1002/ijc.2910460211
Abstract
A computer simulation approach is used to test assumptions about sensitivity of mammography and physical examination, and about the duration of preclinical screendetectable breast cancer. Values between 50% and 80% for the combined sensitivity of the 2 tests give a good explanation of the results of the HIP randomized trial of breast cancer screening. The mean duration of the preclinical stage can vary from 1.6 years for high sensitivity values to 2.7 years for low values. In comparison with previous analyses of the HIP data, our estimate for the sensitivity is lower, and the mean duration of the preclinical stage is longer. This is a consequence of the use of a more detailed model in our analysis, allowing for a more complete use of the HIP data in testing model assumptions. Similar analyses of data from recent screening projects in The Netherlands resulted in compatible estimates for the duration of preclinical breast cancer.Keywords
This publication has 26 references indexed in Scilit:
- The cost‐effectiveness of breast cancer screeningInternational Journal of Cancer, 1989
- The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.Journal of Epidemiology and Community Health, 1989
- Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial.BMJ, 1988
- Analysis of Breast Cancer Mortality and Stage Distribution by Age for the Health Insurance Plan Clinical TrialJNCI Journal of the National Cancer Institute, 1988
- EVALUATION OF SCREENING FOR BREAST CANCER IN A NON-RANDOMISED STUDY (THE DOM PROJECT) BY MEANS OF A CASE-CONTROL STUDYThe Lancet, 1984
- REDUCTION OF BREAST CANCER MORTALITY THROUGH MASS SCREENING WITH MODERN MAMMOGRAPHYThe Lancet, 1984
- An analysis of survival differences between clinically and screen‐detected cancer patientsStatistics in Medicine, 1983
- Predicting the benefit of screening for diseaseJournal of Applied Probability, 1981